Sanofi SA - Research and Development

Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.

The item "Research-and-Development" stands at 8.01 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.

Sanofi SA's third quarter result of 1.83 Billion EUR for the item "Research and Development" represents a decrease of -13.08 percent compared to it's second quarter result.

Also, Sanofi SA's third quarter result of 1.83 Billion EUR for the item "Research and Development" represents a decrease of -0.97 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 8.01 Billion EUR for the item "Research and Development" represents a decrease of -0.22 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 17.12 percent compared to the value the year prior.
The 1 year change in percent is 17.12.
The 3 year change in percent is 23.81.
The 5 year change in percent is 22.35.
The 10 year change in percent is 61.67.

The Serie's long term average value is 5.80 Billion Euros. It's latest available value, on 09/30/2025, is 38.13 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2014, to it's latest available value, on 09/30/2025, is +71.61%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is -0.224%.